These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36252593)

  • 1. Systematic review of pharmacological management in Creutzfeldt-Jakob disease: no options so far?
    Miranda LHL; Oliveira AFPH; Carvalho DM; Souza GMF; Magalhães JGM; Júnior JAC; Lima PTMBQ; Júnior RMA; Filho SPL; Melo HMA
    Arq Neuropsiquiatr; 2022 Aug; 80(8):837-844. PubMed ID: 36252593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights from Therapeutic Studies for PrP Prion Disease.
    Teruya K; Doh-Ura K
    Cold Spring Harb Perspect Med; 2017 Mar; 7(3):. PubMed ID: 27836910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt-Jakob disease.
    Todd NV; Morrow J; Doh-ura K; Dealler S; O'Hare S; Farling P; Duddy M; Rainov NG
    J Infect; 2005 Jun; 50(5):394-6. PubMed ID: 15907546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental treatments for human transmissible spongiform encephalopathies: is there a role for pentosan polysulfate?
    Rainov NG; Tsuboi Y; Krolak-Salmon P; Vighetto A; Doh-Ura K
    Expert Opin Biol Ther; 2007 May; 7(5):713-26. PubMed ID: 17477808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmortem findings in a case of variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulfate.
    Newman PK; Todd NV; Scoones D; Mead S; Knight RS; Will RG; Ironside JW
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):921-4. PubMed ID: 24554103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy in prion diseases.
    Forloni G; Artuso V; Roiter I; Morbin M; Tagliavini F
    Curr Top Med Chem; 2013; 13(19):2465-76. PubMed ID: 24059336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt-Jakob disease: evaluation of a first-in-human treatment programme.
    Mead S; Khalili-Shirazi A; Potter C; Mok T; Nihat A; Hyare H; Canning S; Schmidt C; Campbell T; Darwent L; Muirhead N; Ebsworth N; Hextall P; Wakeling M; Linehan J; Libri V; Williams B; Jaunmuktane Z; Brandner S; Rudge P; Collinge J
    Lancet Neurol; 2022 Apr; 21(4):342-354. PubMed ID: 35305340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of quinacrine administration to patients with Creutzfeldt-Jakob disease.
    Nakajima M; Yamada T; Kusuhara T; Furukawa H; Takahashi M; Yamauchi A; Kataoka Y
    Dement Geriatr Cogn Disord; 2004; 17(3):158-63. PubMed ID: 14739538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Utility of Cerebrospinal Fluid α-Synuclein in Creutzfeldt-Jakob Disease: A Systematic Review and Meta-Analysis.
    Kong Y; Chen Z; Wang X; Wang W; Zhang J
    J Alzheimers Dis; 2022; 89(2):493-503. PubMed ID: 35912746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creutzfeldt-Jakob disease acquired via a dural graft: failure of therapy with quinacrine and chlorpromazine.
    Martínez-Lage JF; Rábano A; Bermejo J; Martínez Pérez M; Guerrero MC; Contreras MA; Lunar A
    Surg Neurol; 2005 Dec; 64(6):542-5, discussion 545. PubMed ID: 16293480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cerebral organoids as a therapeutic drug screening model for Creutzfeldt-Jakob disease.
    Groveman BR; Ferreira NC; Foliaki ST; Walters RO; Winkler CW; Race B; Hughson AG; Zanusso G; Haigh CL
    Sci Rep; 2021 Mar; 11(1):5165. PubMed ID: 33727594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compassionate use of quinacrine in Creutzfeldt-Jakob disease fails to show significant effects.
    Haïk S; Brandel JP; Salomon D; Sazdovitch V; Delasnerie-Lauprêtre N; Laplanche JL; Faucheux BA; Soubrié C; Boher E; Belorgey C; Hauw JJ; Alpérovitch A
    Neurology; 2004 Dec; 63(12):2413-5. PubMed ID: 15623716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Less protease-resistant PrP in a patient with sporadic CJD treated with intraventricular pentosan polysulphate.
    Terada T; Tsuboi Y; Obi T; Doh-ura K; Murayama S; Kitamoto T; Yamada T; Mizoguchi K
    Acta Neurol Scand; 2010 Feb; 121(2):127-30. PubMed ID: 19804470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notification and support for people exposed to the risk of Creutzfeldt-Jakob disease (CJD) (or other prion diseases) through medical treatment (iatrogenically).
    Ryan R; Hill S; Lowe D; Allen K; Taylor M; Mead C
    Cochrane Database Syst Rev; 2011 Mar; (3):CD007578. PubMed ID: 21412905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systematic review of the therapeutics for prion diseases].
    Sakaguchi S
    Brain Nerve; 2009 Aug; 61(8):929-38. PubMed ID: 19697882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial.
    Haïk S; Marcon G; Mallet A; Tettamanti M; Welaratne A; Giaccone G; Azimi S; Pietrini V; Fabreguettes JR; Imperiale D; Cesaro P; Buffa C; Aucan C; Lucca U; Peckeu L; Suardi S; Tranchant C; Zerr I; Houillier C; Redaelli V; Vespignani H; Campanella A; Sellal F; Krasnianski A; Seilhean D; Heinemann U; Sedel F; Canovi M; Gobbi M; Di Fede G; Laplanche JL; Pocchiari M; Salmona M; Forloni G; Brandel JP; Tagliavini F
    Lancet Neurol; 2014 Feb; 13(2):150-8. PubMed ID: 24411709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New knowledge about Creutzfeldt-Jakob disease can yield therapeutic possibilities].
    Stølsmark T; Tysnes OB
    Tidsskr Nor Laegeforen; 2010 Mar; 130(6):601-4. PubMed ID: 20349004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Review of Creutzfeldt-Jakob disease and other prion diseases].
    Zivkovic S; Boada M; López O
    Rev Neurol; 2000 Dec 16-31; 31(12):1171-9. PubMed ID: 11205554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease-resistant PrP and PrP oligomers in the brain in human prion diseases after intraventricular pentosan polysulfate infusion.
    Honda H; Sasaki K; Minaki H; Masui K; Suzuki SO; Doh-Ura K; Iwaki T
    Neuropathology; 2012 Apr; 32(2):124-32. PubMed ID: 21801238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinacrine in possible or probable CJD: if you had suspected CJD would you be indifferent between placebo and quinacrine?
    Braunholtz D; Harris J
    BMJ; 2002 Jan; 324(7331):239. PubMed ID: 11809660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.